Radiation With or Without 6 Months of Androgen Suppression Therapy in Intermediate- and High-Risk Clinically Localized Prostate Cancer: A Postrandomization Analysis by Risk Group
- 27 October 2009
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 77 (4) , 1046-1052
- https://doi.org/10.1016/j.ijrobp.2009.06.038
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Dose-escalated radiation therapy for intermediate-risk prostate cancerCancer, 2009
- Cardiovascular Mortality After Androgen Deprivation Therapy for Locally Advanced Prostate Cancer: RTOG 85-31Journal of Clinical Oncology, 2009
- Causes of death in men undergoing androgen suppression therapy for newly diagnosed localized or recurrent prostate cancerCancer, 2008
- Short-Term Neoadjuvant Androgen Deprivation Therapy and External-Beam Radiotherapy for Locally Advanced Prostate Cancer: Long-Term Results of RTOG 8610Journal of Clinical Oncology, 2008
- Long-Term Results of the M. D. Anderson Randomized Dose-Escalation Trial for Prostate CancerInternational Journal of Radiation Oncology*Biology*Physics, 2008
- Androgen Deprivation Therapy for Localized Prostate Cancer and the Risk of Cardiovascular MortalityJNCI Journal of the National Cancer Institute, 2007
- Influence of Androgen Suppression Therapy for Prostate Cancer on the Frequency and Timing of Fatal Myocardial InfarctionsJournal of Clinical Oncology, 2007
- Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy for Prostate CancerJournal of Clinical Oncology, 2006
- Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and GoserelinNew England Journal of Medicine, 1997
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958